Medicalgorithmics with a Letter of Intent with Diagnostyka Group on VCAST Technology
Medicalgorithmics, a medtech company included in the sWIG80 index, has signed a letter of intent with Diagnostyka Group – the leader in medical diagnostics in Poland – regarding the use of VCAST technology for coronary artery disease examinations. VCAST technology is based on artificial intelligence and is being developed by Kardiolytics, a subsidiary of Medicalgorithmics.
Medicalgorithmics Partners with US IDTF to Provide Software, AI Driven Analytics, and Monitoring Hardware
Medicalgorithmics, SA, a global leader in arrythmia monitoring software and AI-driven analytics, is pleased to announce it entered a definitive agreement to provide a burgeoning independent diagnostic and testing facility (IDTF) based in the southwestern United States with software, AI-driven analytics, and heart monitoring devices.